Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CPB2 | Q96IY4 | 5/20 | 0.51 |
| ▸ | MMP1 | P03956 | 7/20 | 0.44 |
| ▸ | MMP2 | P08253 | 7/20 | 0.44 |
| ▸ | MMP3 | P08254 | 7/20 | 0.44 |
| ▸ | AVPR1A | P37288 | 1/20 | 0.44 |
| ▸ | GRN | P28799 | 1/20 | 0.43 |
| ▸ | SORT1 | Q99523 | 1/20 | 0.43 |
| ▸ | LTA4H | P09960 | 1/20 | 0.41 |
| ▸ | CTSL | P07711 | 1/20 | 0.40 |
| ▸ | CTSB | P07858 | 1/20 | 0.40 |
| ▸ | CTSS | P25774 | 1/20 | 0.40 |
| ▸ | CTSK | P43235 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31294211 | 0.97 | CPB2 (0.48) | CPB2MMP1MMP2MMP3AVPR1A | |
| SCHEMBL31294537 | 0.95 | AVPR1A (0.46) | CPB2MMP1MMP2MMP3AVPR1A | |
| SCHEMBL31294449 | 0.85 | AVPR1A (0.44) | CPB2AVPR1ACTSL | |
| SCHEMBL31294226 | 0.84 | FOLH1 (0.43) | AVPR1AGRNSORT1 | |
| SCHEMBL31229243 | 0.83 | CTSS (0.42) | CPB2AVPR1ACTSS | |
| SCHEMBL31294552 | 0.82 | AVPR1A (0.45) | AVPR1AGRNSORT1 | |
| SCHEMBL31294665 | 0.82 | AVPR1A (0.44) | AVPR1AGRNSORT1 | |
| SCHEMBL31294250 | 0.82 | AVPR1A (0.55) | MMP1AVPR1AGRNSORT1 | |
| SCHEMBL31294631 | 0.82 | GRN (0.53) | MMP3AVPR1AGRNSORT1CTSL | |
| SCHEMBL31294319 | 0.81 | FOLH1 (0.46) | AVPR1AGRNSORT1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4702033-A1 | DESMURAMYLPEPTIDE DIACIDS AS NOD2 AGONISTS AND USE THEREOF | Imhotex Limited (GB) | 2026-03-04 | — | — | EP | disclosed |
| WO-2024224086-A1 | DESMURAMYLPEPTIDE DIACIDS AS NOD2 AGONISTS AND USE THEREOF | Imhotex Limited (GB) | 2024-10-31 | — | — | WO | disclosed |